{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:40Z","timestamp":1790268760069,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024201036"],"award-info":[{"award-number":["H2024201036"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbr.2025.115826","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T04:02:31Z","timestamp":1757822551000},"page":"115826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Low-dose ciprofol attenuates motor dysfunction in PD mice by inhibiting NLRP3 inflammasome activation"],"prefix":"10.1016","volume":"496","author":[{"given":"Yanan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib1","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1007\/s12035-023-03800-2","article-title":"Therapeutic targeting of kr\u00fcppel-like factor 4 and its pharmacological potential in parkinson\u2019s disease: a comprehensive review","volume":"61","author":"Zamanian","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"10423","key":"10.1016\/j.bbr.2025.115826_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.bbr.2025.115826_bib3","doi-asserted-by":"crossref","first-page":"a009258","DOI":"10.1101\/cshperspect.a009258","article-title":"Parkinson's disease and parkinsonism: neuropathology","volume":"2","author":"Dickson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bbr.2025.115826_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"issue":"10291","key":"10.1016\/j.bbr.2025.115826_bib6","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system - associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-neuro-092823-104810","article-title":"Circuit-specific deep brain stimulation provides insights into movement control","volume":"47","author":"Gittis","year":"2024","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.bbr.2025.115826_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbi.2022.09.010","article-title":"Emerging roles of leptin in parkinson's disease: chronic inflammation, neuroprotection and more?","volume":"107","author":"Regensburger","year":"2023","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbr.2025.115826_bib10","first-page":"2062","article-title":"Effects of sevoflurane on leucine-rich repeat kinase 2-associated drosophila model of parkinson's disease","volume":"11","author":"Shan","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bbr.2025.115826_bib11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1213\/ANE.0000000000005665","article-title":"Anesthetic effects on the progression of parkinson disease in the rat dj-1 model","volume":"133","author":"Xu","year":"2021","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbr.2025.115826_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174806","article-title":"Dexmedetomidine attenuates motor deficits via restoring the function of neurons in the nigrostriatal circuit in parkinson's disease model mice","volume":"920","author":"Zhou","year":"2022","journal-title":"Eur. J. Pharm."},{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib13","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1016\/j.sjbs.2021.04.013","article-title":"Dexmedetomidine protects against degeneration of dopaminergic neurons and improves motor activity in parkinson's disease mice model","volume":"28","author":"Zhang","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3892\/mmr.2015.4570","article-title":"Propofol protects against the neurotoxicity of 1\u2011methyl\u20114\u2011phenylpyridinium","volume":"13","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbr.2025.115826_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainres.2011.02.079","article-title":"Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an mptp-induced murine model of parkinson's disease","volume":"1387","author":"Kubo","year":"2011","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.bbr.2025.115826_bib16","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1007\/s12325-021-01914-4","article-title":"Sedation effects produced by a ciprofol initial infusion or bolus dose followed by continuous maintenance infusion in healthy subjects: a phase 1 trial","volume":"38","author":"Hu","year":"2021","journal-title":"Adv. Ther."},{"issue":"9","key":"10.1016\/j.bbr.2025.115826_bib17","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1021\/acs.jmedchem.7b00254","article-title":"Design, synthesis, and evaluation of novel 2,6-disubstituted phenol derivatives as general anesthetics","volume":"60","author":"Qin","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbr.2025.115826_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1037151","article-title":"Ciprofol attenuates the isoproterenol-induced oxidative damage, inflammatory response and cardiomyocyte apoptosis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharm."},{"issue":"4","key":"10.1016\/j.bbr.2025.115826_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10142-023-01273-z","article-title":"Nrf2 attenuates oxidative stress to mediate the protective effect of ciprofol against cerebral ischemia-reperfusion injury","volume":"23","author":"Liu","year":"2023","journal-title":"Funct. Integr. Genom."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bcp.14363","article-title":"Mass balance, pharmacokinetics and pharmacodynamics of intravenous hsk3486, a novel anaesthetic, administered to healthy subjects","volume":"87","author":"Bian","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbr.2025.115826_bib21","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1021\/acs.jmedchem.7b00254","article-title":"Design, synthesis, and evaluation of novel 2,6-disubstituted phenol derivatives as general anesthetics","volume":"60","author":"Qin","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbr.2025.115826_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/EJA.0000000000001759","article-title":"Efficacy and safety of ciprofol for general anaesthesia induction in elderly patients undergoing major noncardiac surgery: a randomised controlled pilot trial","volume":"39","author":"Ding","year":"2022","journal-title":"Eur. J. Anaesthesiol."},{"issue":"2","key":"10.1016\/j.bbr.2025.115826_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1066","article-title":"Clinical effect of different doses of ciprofol for induction of general anesthesia in elderly patients: a randomized, controlled trial","volume":"11","author":"Duan","year":"2023","journal-title":"Pharm. Res. Perspect."},{"issue":"12","key":"10.1016\/j.bbr.2025.115826_bib24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/EJA.0000000000001759","article-title":"Efficacy and safety of ciprofol for general anaesthesia induction in elderly patients undergoing major noncardiac surgery","volume":"39","author":"Ding","year":"2022","journal-title":"Eur. J. Anaesthesiol."},{"issue":"2","key":"10.1016\/j.bbr.2025.115826_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1066","article-title":"Clinical effect of different doses of ciprofol for induction of general anesthesia in elderly patients: a randomized, controlled trial","volume":"11","author":"Duan","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"issue":"4","key":"10.1016\/j.bbr.2025.115826_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after mptp exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.bbr.2025.115826_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"M. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6tetrahydropyridin","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with parkinson's disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.bbr.2025.115826_bib29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.bbr.2025.115826_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17020151","article-title":"Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the mptp mouse model of parkinson\u2019s disease-lessons from transgenic mice","volume":"17","author":"Machado","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bbr.2025.115826_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of parkinson's disease","volume":"38","author":"Joh","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.bbr.2025.115826_bib32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","article-title":"Inflammasome assembly in neurodegenerative diseases","volume":"46","author":"Singh","year":"2023","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.bbr.2025.115826_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41418-018-0124-5","article-title":"Mptp-driven nlrp3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration","volume":"26","author":"Lee","year":"2018","journal-title":"Cell Death Differ."},{"issue":"465","key":"10.1016\/j.bbr.2025.115826_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial nlrp3 and represses neurodegeneration in parkinson's disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.bbr.2025.115826_bib36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.15699","article-title":"Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic mptp mouse model of parkinson\u02bcs disease","volume":"164","author":"Santoro","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2025.115826_bib37","article-title":"Reassessment of subacute mptp-treated mice as__animal model of parkinson\u2019s disease","author":"CHEN","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the mptp mouse model of parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbr.2025.115826_bib39","article-title":"The impact of inflammation and general anesthesia on memory and executive function in mice","author":"Khodaei","year":"2022","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.bbr.2025.115826_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174806","article-title":"Dexmedetomidine attenuates motor deficits via restoring the function of neurons in the nigrostriatal circuit in parkinson's disease model mice","volume":"920","author":"Zhou","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115826_bib41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bbi.2019.07.026","article-title":"Il-17a exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of parkinson's disease","volume":"81","author":"Liu","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbr.2025.115826_bib42","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"L. A. L. Characterization of progressive motor deficits in mice transgenic-for the human huntington\u2019s disease mutation","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2025.115826_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154281","article-title":"Mangiferin, a natural glucoxilxanthone, inhibits mitochondrial dynamin-related protein 1 and relieves aberrant mitophagic proteins in mice model of parkinson's disease","volume":"104","author":"Wang","year":"2022","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bbr.2025.115826_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1017\/cjn.2017.268","article-title":"Effects of ginkgo biloba extract on a53t \u03b1-synuclein transgenic mouse models of parkinson\u2019s disease","volume":"45","author":"Kuang","year":"2017","journal-title":"Can. J. Neurol. Sci. \/ J. Can. Des. Sci. Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2025.115826_bib45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/jcbfm.2012.185","article-title":"Assessing post-stroke behavior in mouse models of focal ischemia","volume":"33","author":"Balkaya","year":"2012","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02494-y","article-title":"The circadian clock protein rev-erb\u03b1 provides neuroprotection and attenuates neuroinflammation against parkinson\u2019s disease via the microglial nlrp3 inflammasome","volume":"19","author":"Kou","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbr.2025.115826_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102134","article-title":"The nrf2-nlrp3-caspase-1 axis mediates the neuroprotective effects of celastrol in parkinson's disease","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.bbr.2025.115826_bib48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","article-title":"Dopamine d2 receptor restricts astrocytic nlrp3 inflammasome activation via enhancing the interaction of \u03b2-arrestin2 and nlrp3","volume":"25","author":"Zhu","year":"2018","journal-title":"Cell Death Differ."},{"issue":"15","key":"10.1016\/j.bbr.2025.115826_bib49","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","article-title":"Neuronal nlrp3 is a parkin substrate that drives neurodegeneration in parkinson\u2019s disease","volume":"110","author":"Panicker","year":"2022","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bbr.2025.115826_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13770-019-00194-y","article-title":"Propofol suppresses lps-induced inflammation in amnion cells via inhibition of nf-\u03bab activation","volume":"16","author":"Yoon","year":"2019","journal-title":"Tissue Eng. Regen. Med."},{"issue":"5","key":"10.1016\/j.bbr.2025.115826_bib51","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00011-014-0713-9","article-title":"Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia","volume":"63","author":"Peng","year":"2014","journal-title":"Inflamm. Res."},{"issue":"11","key":"10.1016\/j.bbr.2025.115826_bib52","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.immuni.2023.10.004","article-title":"Gasdermin d permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis","volume":"56","author":"Miao","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib53","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-02061-3","article-title":"Propofol suppresses microglial phagocytosis through the downregulation of mfg-e8","volume":"18","author":"Cai","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.bbr.2025.115826_bib54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"issue":"s1","key":"10.1016\/j.bbr.2025.115826_bib55","first-page":"S3","article-title":"The emerging evidence of the parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"issue":"12","key":"10.1016\/j.bbr.2025.115826_bib56","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1002\/mds.28762","article-title":"Prevalence of parkinson's disease: a community-based study in China","volume":"36","author":"Qi","year":"2021","journal-title":"Mov. Disord."},{"issue":"S1","key":"10.1016\/j.bbr.2025.115826_bib57","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/anae.15617","article-title":"Peri-operative management of patients with parkinson\u2019s disease","volume":"77","author":"Yim","year":"2022","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/7443226","article-title":"Ciprofol: a novel alternative to propofol in clinical intravenous anesthesia?","volume":"2023","author":"Lu","year":"2023","journal-title":"BioMed. Res. Int."},{"issue":"20","key":"10.1016\/j.bbr.2025.115826_bib59","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1021\/acs.jmedchem.7b01133","article-title":"Oral delivery of propofol with methoxymethylphosphonic acid as the delivery vehicle","volume":"60","author":"Wei","year":"2017","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bbr.2025.115826_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22634","article-title":"Efficacy and safety of ciprofol (hsk3486) for procedural sedation and anesthesia induction in surgical patients: a systematic review and meta-analysis","volume":"9","author":"Wen","year":"2023","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.bbr.2025.115826_bib61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/ALN.0000000000004886","article-title":"Comparison of the efficacy of hsk3486 and propofol for induction of general anesthesia in adults: a multicenter, randomized, double-blind, controlled, phase 3 noninferiority trial","volume":"140","author":"Gan","year":"2024","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib62","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s10571-023-01350-8","article-title":"Parkinson\u2019s disease risk and hyperhomocysteinemia: the possible link","volume":"43","author":"Al-kuraishy","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbr.2025.115826_bib63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of nlrp3 inflammasome\/pyroptosis activation and their role in parkinson's disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12035-023-03561-y","article-title":"Role of brain liver x receptor in parkinson\u2019s disease: hidden treasure and emerging opportunities","volume":"61","author":"Alnaaim","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbr.2025.115826_bib65","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/npr2.12445","article-title":"Role of uric acid in neurodegenerative diseases, focusing on alzheimer and parkinson disease: a new perspective","volume":"44","author":"Alrouji","year":"2024","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"13","key":"10.1016\/j.bbr.2025.115826_bib66","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jcmm.17784","article-title":"Nf-\u03bab\/nlrp3 inflammasome axis and risk of parkinson's disease in type 2 diabetes mellitus: a narrative review and new perspective","volume":"27","author":"Alrouji","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbr.2025.115826_bib67","article-title":"Common nlrp3 inflammasome inhibitors and covid-19: divide and conquer","volume":"18","author":"Batiha","year":"2022","journal-title":"Sci. Afr."},{"key":"10.1016\/j.bbr.2025.115826_bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","article-title":"Mitochondrial impairment in microglia amplifies nlrp3 inflammasome proinflammatory signaling in cell culture and animal models of parkinson's disease","volume":"3","author":"Sarkar","year":"2017","journal-title":"NPJ Park. Dis."},{"issue":"8","key":"10.1016\/j.bbr.2025.115826_bib69","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.18632\/aging.202837","article-title":"Inhibition of long non-coding rna hoxa11-as against neuroinflammation in parkinson's disease model via targeting mir-124-3p mediated fstl1\/nf-kappab axis","volume":"13","author":"Cao","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.bbr.2025.115826_bib70","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.omtn.2021.01.022","article-title":"Exosomes derived from mir-188-3p-modified adipose-derived mesenchymal stem cells protect parkinson's disease","volume":"23","author":"Li","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.bbr.2025.115826_bib71","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-018-1236-z","article-title":"Inhibition of the hepatic nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a mptp\/p mouse model of parkinson\u2019s disease","volume":"15","author":"Qiao","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"11","key":"10.1016\/j.bbr.2025.115826_bib72","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.it.2022.09.010","article-title":"Parkinson's disease: connecting mitochondria to inflammasomes","volume":"43","author":"Lawrence","year":"2022","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.bbr.2025.115826_bib73","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2020.11815","article-title":"Propofol ameliorates endotoxin\u2011induced myocardial cell injury by inhibiting inflammation and apoptosis via the ppargamma\/hmgb1\/nlrp3 axis","volume":"23","author":"Zhao","year":"2021","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.bbr.2025.115826_bib74","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s10753-016-0446-8","article-title":"Propofol inhibits nlrp3 inflammasome and attenuates blast-induced traumatic brain injury in rats","volume":"39","author":"Ma","year":"2016","journal-title":"Inflammation"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825004139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432825004139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:07:15Z","timestamp":1780304835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432825004139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":74,"alternative-id":["S0166432825004139"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115826","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose ciprofol attenuates motor dysfunction in PD mice by inhibiting NLRP3 inflammasome activation","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115826"}}